Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 159

1.

A new era in rheumatoid arthritis treatment.

Costello JC, Halverson PB.

WMJ. 2003;102(7):29-33. Review.

PMID:
14711021
[PubMed - indexed for MEDLINE]
Free Article
2.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

PMID:
17049139
[PubMed - indexed for MEDLINE]
Free Article
3.

[New drugs and treatment strategies for rheumatoid arthritis].

Fantini F.

Recenti Prog Med. 2003 Sep;94(9):361-79. Review. Italian.

PMID:
12942798
[PubMed - indexed for MEDLINE]
4.

Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.

Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A.

Int J Rheum Dis. 2012 Jun;15(3):330-5. doi: 10.1111/j.1756-185X.2012.01715.x. Epub 2012 Feb 13.

PMID:
22709496
[PubMed - indexed for MEDLINE]
5.

Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study.

Markatseli TE, Alamanos Y, Saougou I, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1):31-8. Epub 2012 Mar 6.

PMID:
22153557
[PubMed - indexed for MEDLINE]
6.

[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].

Bombardieri S, Ferraccioli G, Ferri C, Galeazzi M, Lapadula G, Cerinic MM, Montecucco C, Triolo G, Trotta F, Valentini G.

Reumatismo. 2009 Apr-Jun;61 Suppl 1:1-23. Italian.

PMID:
19999184
[PubMed - indexed for MEDLINE]
7.

Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritis.

Inanc N, Direskeneli H.

Rheumatol Int. 2006 Nov;27(1):67-71. Epub 2006 Aug 2.

PMID:
16896990
[PubMed - indexed for MEDLINE]
8.

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, Dackhammar C, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Rantapää-Dahlqvist S, Saxne T, Klareskog L.

Arthritis Rheum. 2009 Nov;60(11):3180-9. doi: 10.1002/art.24941.

PMID:
19877027
[PubMed - indexed for MEDLINE]
Free Article
9.

Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody.

Baker DE.

Rev Gastroenterol Disord. 2004 Fall;4(4):196-210.

PMID:
15580154
[PubMed - indexed for MEDLINE]
10.

[Biological agents targeting on pro-inflammatory cytokines].

Takeuchi T.

Nihon Rinsho. 2005 Sep;63(9):1601-6. Review. Japanese.

PMID:
16164218
[PubMed - indexed for MEDLINE]
11.

[How I treat...rheumatoid arthritis. The arrival of a new therapeutic era: anti-tumor necrosis factor alpha antibodies].

Kaiser MJ, Malaise MG.

Rev Med Liege. 2002 Aug;57(8):486-92. Review. French.

PMID:
12405019
[PubMed - indexed for MEDLINE]
12.

[Review of the protective effects of tumor necrosis factor inhibitors in rheumatoid arthritis].

Finckh A, Gabay C, Guerne PA.

Rev Med Suisse Romande. 2004 Sep;124(9):547-50. Review. French.

PMID:
15552748
[PubMed - indexed for MEDLINE]
13.

Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.

Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A.

Drug Saf. 2002;25(3):173-97. Review.

PMID:
11945114
[PubMed - indexed for MEDLINE]
14.

[Biologicals in treatment of rheumatoid arthritis and other inflammatory arthropathies].

Sautner J, Leeb BF.

Wien Med Wochenschr. 2003;153(13-14):304-8. Review. German.

PMID:
12924105
[PubMed - indexed for MEDLINE]
15.

Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment.

Levälampi T, Korpela M, Vuolteenaho K, Moilanen E.

Rheumatol Int. 2008 Jan;28(3):261-9. Epub 2007 Sep 6.

PMID:
17846778
[PubMed - indexed for MEDLINE]
16.

Clinical application and evaluation of anti-TNF-alpha agents for the treatment of rheumatoid arthritis.

Jin J, Chang Y, Wei W.

Acta Pharmacol Sin. 2010 Sep;31(9):1133-40. doi: 10.1038/aps.2010.134. Epub 2010 Aug 16. Review.

PMID:
20711219
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Differentiating the efficacy of tumor necrosis factor inhibitors.

Haraoui B.

J Rheumatol Suppl. 2005 Mar;74:3-7. Review.

PMID:
15742457
[PubMed - indexed for MEDLINE]
18.

Etanercept in rheumatoid arthritis.

Alldred A.

Expert Opin Pharmacother. 2001 Jul;2(7):1137-48. Review.

PMID:
11583065
[PubMed - indexed for MEDLINE]
19.

[Daily practice using the guidelines for prevention and treatment of osteoporosis. The effects of anti-TNF therapy on bone and joint manifestations in rheumatoid arthritis].

Soen S.

Clin Calcium. 2008 Aug;18(8):1169-75. doi: CliCa080811691175. Review. Japanese.

PMID:
18677056
[PubMed - indexed for MEDLINE]
20.

Advances in the treatment of rheumatoid arthritis: old versus new therapies.

Saravanan V, Hamilton J.

Expert Opin Pharmacother. 2002 Jul;3(7):845-56. Review.

PMID:
12083985
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk